# Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

> **NCT01475669** · PHASE3 · COMPLETED · sponsor: **CSL Behring** · enrollment: 152 (actual)

## Conditions studied

- Surgical Blood Loss
- Postoperative Blood Loss

## Interventions

- **BIOLOGICAL:** Fibrinogen Concentrate (Human) (FCH)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01475669
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-09
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2014-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475669, "Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01475669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*